Literature DB >> 18030620

Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis.

Deepak Kumar Singh1, Puja Sakhuja, Veena Malhotra, Ranjana Gondal, Shiv Kumar Sarin.   

Abstract

AIM: To identify the clinical and biochemical predictors of histologic disease severity in patients with non-alcoholic steatohepatitis (NASH).
METHOD: Clinical, anthropometric and biochemical data of 71 consecutive patients with a histological diagnosis of NASH were retrieved from the medical database. The histologic criteria proposed at the American Association for the Study of Liver Diseases Conference (2003) were followed. Histologic features and the necro-inflammatory grade of liver biopsy were scored in accordance with the Brunt score. Statistical analysis was performed to identify predictors of disease severity.
RESULTS: The male to female ratio of the study cohort was 3.1:1. The mean body mass index (BMI) of the patients was 25.67 +/- 1.9 kg/m2. In terms of necroinflammatory grading, 21 (29.6%) patients were classified as grade 1, 26 (36.6%) as grade 2 and 24 (33.8%) as grade 3. Multivariate analysis revealed that BMI (P = 0.009), waist circumference (P = 0.035), waist:hip ratio (P = 0.011) and aspartate aminotransferase levels (P < 0.001) were independent predictors of necroinflammatory grade and that female gender (P = 0.02), serum alkaline phosphatase levels (P = 0.018), cholesterol levels (P = 0.048) and low-density lipoprotein (LDL) levels (P = 0.025) were independent predictors of fibrosis stage.
CONCLUSION: Female gender, BMI, waist:hip ratio, hypercholesterolemia and LDL levels are independent predictors of disease severity in patients with NASH and may influence the decision to biopsy.

Entities:  

Mesh:

Year:  2007        PMID: 18030620     DOI: 10.1007/s10620-007-0074-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  46 in total

1.  Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.

Authors:  J B Dixon; P S Bhathal; P E O'Brien
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

2.  Nonalcoholic steatohepatitis: clinicopathological profile.

Authors:  D N Amarapurkar; A D Amarapurkar
Journal:  J Assoc Physicians India       Date:  2000-03

3.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

4.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

5.  Waist circumference, waist-to-hip ratio and body mass index as predictors of adipose tissue compartments in men.

Authors:  D C Chan; G F Watts; P H R Barrett; V Burke
Journal:  QJM       Date:  2003-06

6.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

Review 7.  Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?

Authors:  Geoffrey C Farrell
Journal:  J Gastroenterol Hepatol       Date:  2003-02       Impact factor: 4.029

8.  Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients.

Authors:  H C Pinto; A Baptista; M E Camilo; A Valente; A Saragoça; M C de Moura
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

9.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

10.  The natural history of nonalcoholic fatty liver: a follow-up study.

Authors:  M R Teli; O F James; A D Burt; M K Bennett; C P Day
Journal:  Hepatology       Date:  1995-12       Impact factor: 17.425

View more
  17 in total

1.  Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  Hüseyin Saadettin Uslusoy; Selim Giray Nak; Macit Gülten
Journal:  World J Hepatol       Date:  2011-08-27

2.  NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).

Authors:  Miriam B Vos; Stephanie H Abrams; Sarah E Barlow; Sonia Caprio; Stephen R Daniels; Rohit Kohli; Marialena Mouzaki; Pushpa Sathya; Jeffrey B Schwimmer; Shikha S Sundaram; Stavra A Xanthakos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

Review 3.  Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.

Authors:  Ajay Duseja; Shivaram P Singh; Vivek A Saraswat; Subrat K Acharya; Yogesh K Chawla; Subhankar Chowdhury; Radha K Dhiman; Rohinivilasam V Jayakumar; Kaushal Madan; Sri P Misra; Hrudananda Mishra; Sunil K Modi; Arumugam Muruganathan; Banshi Saboo; Rakesh Sahay; Rajesh Upadhyay
Journal:  J Clin Exp Hepatol       Date:  2015-03-06

Review 4.  Nonalcoholic fatty liver disease in India - a lot done, yet more required!

Authors:  Ajay Duseja
Journal:  Indian J Gastroenterol       Date:  2010-12-30

5.  Risk factors and mechanisms of non-alcoholic steatohepatitis.

Authors:  Chantal A Rivera
Journal:  Pathophysiology       Date:  2008-07-29

6.  Farnesoid X receptor deficiency induces nonalcoholic steatohepatitis in low-density lipoprotein receptor-knockout mice fed a high-fat diet.

Authors:  Bo Kong; James P Luyendyk; Ossama Tawfik; Grace L Guo
Journal:  J Pharmacol Exp Ther       Date:  2008-10-23       Impact factor: 4.030

7.  Simple biochemical parameters and a novel score correlate with absence of fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Akash Shukla; Swapnali Kapileswar; Nithya Gogtay; Amita Joshi; Prashant Dhore; Chirag Shah; Philip Abraham; Shobna Bhatia
Journal:  Indian J Gastroenterol       Date:  2015-09-04

8.  Biopsy Proven Fibrosis in Non-Alcoholic Fatty Liver Disease: An Analysis of Risk Factors.

Authors:  Kaumudee Pattnaik; Pallavi Bhuyan; Ayaskant Singh; Shivaram P Singh; Preetam Nath; Sanjib Kar; Bijay Misra; Jayashree Rath
Journal:  J Clin Exp Hepatol       Date:  2018-01-08

9.  NAFLD in women: Unique pathways, biomarkers and therapeutic opportunities.

Authors:  Liyun Yuan; Ani Kardashian; Monika Sarkar
Journal:  Curr Hepatol Rep       Date:  2019-11-18

10.  Predictors of non-alcoholic fatty liver disease in obese and overweight Egyptian children: single center study.

Authors:  Hanaa M el-Karaksy; Nehal M el-Koofy; Ghada M Anwar; Fatma M el-Mougy; Ahmed el-Hennawy; Mona E Fahmy
Journal:  Saudi J Gastroenterol       Date:  2011 Jan-Feb       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.